Fentanyl Phase 2 Trial met all endpoints; Phase 3 planned for H1 2027 CAMBRIDGE, Mass., Oct. 1, 2026 /PRNewswire/ -- Clear Scientific, Inc. today announced positive top-line results from its Phase 2 trial of CS-1103, a small-molecule sequestrant that immediately binds and inactivates...
Hence then, the article about clear scientific reports positive phase 2 results for cs 1103 the first investigational therapeutic that removes fentanyl from the body was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Clear Scientific Reports Positive Phase 2 Results for CS-1103, the First Investigational Therapeutic That Removes Fentanyl from the Body )
Also on site :
- APOD: 2026 October 1 – Harvest Moon with Erupting Mount Etna
- ‘KPop Demon Hunters 2’ Targeting “A Very Broad Theatrical Release,” Netflix Co-CEO Ted Sarandos Says, Addressing Streamer’s Distribution Strategy
- Witney Carson Defends Guillermo Rodriguez’s Success Amid ‘DWTS’ Elimination Controversy: ‘He Deserves It’